Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

26 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

ITALY

TOSCANA
FIRENZE

Ongoing trial
Randomized Controlled Trial for Testing the Efficacy of Well-Being Therapy in Patients With Systemic Sclerosis
Università degli studi di Firenze
Dipartimento di Scienze della Salute

NETHERLANDS

Utrecht
UTRECHT

ITALY

MARCHE
ANCONA

Recruiting trial
Ongoing trial
High dose intravenous N-Acetylcysteine vs Iloprost for Early, rapidly progressive diffuse systemic Sclerosis
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

ITALY

MARCHE
ANCONA

Ongoing trial
Low-dose oral Imatinib in the treatment of Scleroderma pulmonary involvement: a phase II pilot sutdy
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

UNITED KINGDOM

Greater London
LONDON

Multinational clinical trial(s)